The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Man who ‘begged’ NHS for weightloss jabs drops nine stone after going private - Mark Spurr dropped nine stone after starting ...

THE family of a man who died after taking Mounjaro want a probe into the weight-loss drug’s “potential to kill”. It comes after The Sun revealed 82 deaths have been linked to anti-fat and diabetes ...

“Mounjaro’s changed my life and it might have even saved my life,” Mark said. “I couldn’t walk across the car park in June ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug ...

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk’s ...

Around 82 people has died after using weight-loss and diabetes jabs such as Ozempic and Mounjaro. Up to the end of January, ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, Wegovy and Ozempic.

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

If Australia followed England’s lead and listed drugs such as Wegovy on the PBS for weight loss, this could bring the cost ...